Did you notice right after Abakus announced the Munchie Cup in Aspen (August 18-20), the New York Times published a reefer madness story saying the medibles in Colorado are too strong, all based around a famished reporter eating an entire medible candy bar on an empty stomach?
Consequently, the medible industry was thrown into a fake crisis, and several companies started reducing active ingredient levels in products, a great tragedy, while state regulators discouraged bite-sized products containing the maximum 100 milligram dose.
In fact, people with serious illness and/or extreme pain require very high doses, and this panic forces them to spend more money on medicine. Many companies had moved to stronger medibles as a reaction to patient demand, and if anything, the regulators should be encouraging dosages to move higher, not lower. According to Rick Simpson, it requires 60 grams of oil in one month to clear most cancers. But if you are limited to 100 milligrams per day, you aren’t going to come close, are you?
Of course, the real problem is labeling. We really need two kinds of medibles: a low-dose version for patients who do not desire or need a large amount of cannabis, and a high-dose version for the patients with a serious conditions that demand high dosages. A warning label should appear on all medibles, along with instructions for quelling a panic attack. But the warning label on the high-dose medible should be larger and draw real attention and serve to warn the unsuspecting consumer they are holding a serious amount of medicine and not something to play around with and chow down on an empty stomach, unless of course, you are only doing that to jump start a media scare and make it harder for people to get medicine.